-
AACR Conference 2015: What to Expect
The American Association for Cancer Research (AACR) will hold its annual meeting this week. Here is a…
-
Across the CEO’s Desk: February 2015 Roundup
CRI's CEO Jill O'Donnell-Tormey, PhD, shares some of the latest news in cancer immunotherapy.
-
New Cancer Immunotherapy Opdivo Approved by FDA
Just hours ago, the FDA approved Bristol-Myers Squibb's PD-1 drug for melanoma.
-
Immunotherapy for Blood Cancers: What to Look for at the Upcoming ASH Meeting
Look for the latest results from trials of PD-1 inhibitors and new developments in adoptive cell transfer.
-
FDA Approves New Cancer Immunotherapy
Merck's new immunotherapy, Keytruda (pembrolizumab), was approved today by the FDA, making it the first PD-1 inhibitor…
-
A Unique Approach to Translational Research
CRI is placing an increasing emphasis on the translation and clinical application of scientific discovery and identifying…
